Anticardiolipin antibody levels in ischemic stroke İskemi̇k i̇nmeli̇ olgularda anti̇kardi̇oli̇ pi̇n anti̇kor düzeyleri̇
Turk Beyin Damar Hastaliklar Dergisi, cilt.10, sa.1, ss.45-50, 2004 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 10 Sayı: 1
- Basım Tarihi: 2004
- Dergi Adı: Turk Beyin Damar Hastaliklar Dergisi
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.45-50
- Anahtar Kelimeler: Anticardiolipin antibody IgG, Anticardiolipin antibody IgM, Ischemic stroke, Risk factor
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
PURPOSE: Many aetiological risk factors have been known to play important roles in the development of ischemic cerebrovascular diseases. Among these risk factors, attention has been focused on high levels of anticardiolipin antibodies (ACA). This study aims to evaluate levels of ACA IgG and IgM in ischemic cerebrovascular diseases. MATERIAL AND METHOD: This study includes 60 patient and a control group of 30. In the study, for each patient brain imaging study (CT or MRI), echocardiography (TTE or TEE), doppler USG and rutin heamatological examinations were also performed. Levels of ACA IgG and IgM were studies in the serum samples taken from each patient within the first week. FINDINGS: The patients (n:60) and the control group (n:30) were divided into age groups of under 40, 40-60 and over 60. When examined according to age, statisticaly, no significant differences were found. In the patient group average levels of IgG ACA (PLU/ml) were 4.15 for the first group, 4.40 for the second and 3.55 for the third group. Average levels of IgM ACA (PLU/ml) were 4.85, 3.10 and 1.70 respectively. As for the control group average levels ogf IgG ACA were 3.20, 3.10, 4.60 PLU/ml, and average levels of IgM ACA weere 2.60, 4.80, 1.50 PLU/ml respectively. CONCLUSION: According to our data, there has been no significant differences statisticaly, in levels of IgG and IgM ACA between the patient and control group (p>0.05), which suggests that these levels do not constitute risk factors in stroke.